Medgend Icon







discontinued


Bimatoprost FDA Approved Drugs

BIMATOPROST [BimatoprostC25H37NO4]
RX
-
0.03% (topical solution/drops)
Apotex IncDec 1, 2014
Lupin LtdFeb 20, 2015
Sandoz IncApr 19, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LATISSE [BimatoprostC25H37NO4]
RX
-
0.03% (topical solution/drops)
AllerganDec 24, 2008
  • Method of increasing eyelash growth including length, thickness, darkness and/or number of eyelashes by administering bimatoprost to an eyelid margin.
  • Method of increasing eyelash growth with bimatoprost.
  • Method of increasing eyelash growth.
  • Method of increasing growth of hair including eyelashes.
  • Method of increasing hair growth.
  • Method of stimulating hair growth.
  • Treatment of hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LUMIGAN [BimatoprostC25H37NO4]
RX
-
0.01% (ophthalmic solution/drops)
AllerganAug 31, 2010
  • A method of lowering intraocular pressure in a patient with open angle glaucoma or ocular hypertension.
  • A method of lowering intraocular pressure.
  • A method of reducing intraocular pressure in patients with open angle glaucoma or ocular hypertension.
  • A method of treating a patient with glaucoma or ocular hypertension.
  • Method of treating glaucoma in a patient.
  • Method of treating glaucoma or elevated intraocular pressure.
  • Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.